FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912261475> ?p ?o ?g. }

• W2912261475 endingPage "1281" @default.
• W2912261475 startingPage "1276" @default.
• W2912261475 abstract "To determine the long-term risk of diabetes in a cohort of children treated with recombinant human growth hormone in Israel, using data from the Israeli National Diabetes Register.Between 1988 and 2009, 2513 children were approved for growth hormone treatment. They were assigned to one of two groups. The first group included children treated for isolated growth hormone deficiency and who were small for gestational age and the second included those treated for multiple pituitary hormone deficiency, chronic renal failure, Turner syndrome or Prader-Willi syndrome. The cohort was cross-linked with the Israeli National Diabetes Register for 2014 (mean follow-up duration 12.1±5.3 years), and prevalent cases of diabetes were identified. Standardized prevalence ratios for diabetes were calculated for people aged 10-29 years.In 2014, a total of 23 individuals were identified with diabetes (four with pre-existing diabetes, seven developed diabetes before age 17 years and 12 developed it at a later age). In the isolated growth hormone deficiency and small-for-gestational-age group there was no difference in the prevalence of diabetes compared with the general population (standardized prevalence ratio 2.05, 95% CI 0.94-3.89). In the group that included people with multiple pituitary hormone deficiency, chronic renal failure, Turner syndrome and Prader-Willi syndrome there was a significantly higher diabetes prevalence (standardized prevalence ratio 11.94, 95% CI 6.53-20.00) compared with the general population.No difference in diabetes prevalence was found in the isolated growth hormone deficiency and small-for-gestational-age group, compared with the general population. Children treated with growth hormone with pre-existing risk factors had an increased prevalence of diabetes. It is advisable to monitor blood glucose levels closely during and after growth hormone treatment, especially in such children." @default.
• W2912261475 created "2019-02-21" @default.
• W2912261475 creator A5001536043 @default.
• W2912261475 creator A5008478471 @default.
• W2912261475 creator A5019568304 @default.
• W2912261475 creator A5022206028 @default.
• W2912261475 creator A5046825683 @default.
• W2912261475 creator A5068666135 @default.
• W2912261475 creator A5090768607 @default.
• W2912261475 date "2019-02-21" @default.
• W2912261475 modified "2023-09-27" @default.
• W2912261475 title "Prevalence of diabetes among children treated with growth hormone in Israel" @default.
• W2912261475 cites W1775160221 @default.
• W2912261475 cites W1964730195 @default.
• W2912261475 cites W1973254353 @default.
• W2912261475 cites W1984510069 @default.
• W2912261475 cites W1987602962 @default.
• W2912261475 cites W1996154589 @default.
• W2912261475 cites W1998850554 @default.
• W2912261475 cites W2034399638 @default.
• W2912261475 cites W2038913799 @default.
• W2912261475 cites W2061593979 @default.
• W2912261475 cites W2070777958 @default.
• W2912261475 cites W2072801273 @default.
• W2912261475 cites W2080710150 @default.
• W2912261475 cites W2103131841 @default.
• W2912261475 cites W2113917785 @default.
• W2912261475 cites W2124330927 @default.
• W2912261475 cites W2139470982 @default.
• W2912261475 cites W2150210382 @default.
• W2912261475 cites W2152371714 @default.
• W2912261475 cites W2163182044 @default.
• W2912261475 cites W2163954745 @default.
• W2912261475 cites W2186201736 @default.
• W2912261475 cites W2515433271 @default.
• W2912261475 cites W2555766993 @default.
• W2912261475 cites W2560277678 @default.
• W2912261475 cites W2604299919 @default.
• W2912261475 cites W2765522237 @default.
• W2912261475 cites W4247199011 @default.
• W2912261475 cites W4253330689 @default.
• W2912261475 cites W4300305531 @default.
• W2912261475 doi "https://doi.org/10.1111/dme.13910" @default.
• W2912261475 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30690790" @default.
• W2912261475 hasPublicationYear "2019" @default.
• W2912261475 type Work @default.
• W2912261475 sameAs 2912261475 @default.
• W2912261475 citedByCount "6" @default.
• W2912261475 countsByYear W29122614752019 @default.
• W2912261475 countsByYear W29122614752020 @default.
• W2912261475 countsByYear W29122614752021 @default.
• W2912261475 countsByYear W29122614752022 @default.
• W2912261475 crossrefType "journal-article" @default.
• W2912261475 hasAuthorship W2912261475A5001536043 @default.
• W2912261475 hasAuthorship W2912261475A5008478471 @default.
• W2912261475 hasAuthorship W2912261475A5019568304 @default.
• W2912261475 hasAuthorship W2912261475A5022206028 @default.
• W2912261475 hasAuthorship W2912261475A5046825683 @default.
• W2912261475 hasAuthorship W2912261475A5068666135 @default.
• W2912261475 hasAuthorship W2912261475A5090768607 @default.
• W2912261475 hasBestOaLocation W29122614751 @default.
• W2912261475 hasConcept C126322002 @default.
• W2912261475 hasConcept C134018914 @default.
• W2912261475 hasConcept C187212893 @default.
• W2912261475 hasConcept C2779234561 @default.
• W2912261475 hasConcept C2779434492 @default.
• W2912261475 hasConcept C2779952775 @default.
• W2912261475 hasConcept C2908647359 @default.
• W2912261475 hasConcept C2984496839 @default.
• W2912261475 hasConcept C46973012 @default.
• W2912261475 hasConcept C54355233 @default.
• W2912261475 hasConcept C555293320 @default.
• W2912261475 hasConcept C71315377 @default.
• W2912261475 hasConcept C71924100 @default.
• W2912261475 hasConcept C72563966 @default.
• W2912261475 hasConcept C86803240 @default.
• W2912261475 hasConcept C99454951 @default.
• W2912261475 hasConceptScore W2912261475C126322002 @default.
• W2912261475 hasConceptScore W2912261475C134018914 @default.
• W2912261475 hasConceptScore W2912261475C187212893 @default.
• W2912261475 hasConceptScore W2912261475C2779234561 @default.
• W2912261475 hasConceptScore W2912261475C2779434492 @default.
• W2912261475 hasConceptScore W2912261475C2779952775 @default.
• W2912261475 hasConceptScore W2912261475C2908647359 @default.
• W2912261475 hasConceptScore W2912261475C2984496839 @default.
• W2912261475 hasConceptScore W2912261475C46973012 @default.
• W2912261475 hasConceptScore W2912261475C54355233 @default.
• W2912261475 hasConceptScore W2912261475C555293320 @default.
• W2912261475 hasConceptScore W2912261475C71315377 @default.
• W2912261475 hasConceptScore W2912261475C71924100 @default.
• W2912261475 hasConceptScore W2912261475C72563966 @default.
• W2912261475 hasConceptScore W2912261475C86803240 @default.
• W2912261475 hasConceptScore W2912261475C99454951 @default.
• W2912261475 hasIssue "10" @default.
• W2912261475 hasLocation W29122614751 @default.
• W2912261475 hasLocation W29122614752 @default.
• W2912261475 hasOpenAccess W2912261475 @default.
• W2912261475 hasPrimaryLocation W29122614751 @default.

• next